The Pharmaceutical Journal
Vol 270 No 7253 p821
14 June 2003

This article
Reprint
Photocopy

News summary | R & D summary

New analysis for duloxetine

Lilly says that a new analysis of its investigational antidepressant duloxetine showed higher rates of remission and greater reduction in painful physical symptoms compared with placebo in patients with depression.